5-(Methoxymethyl)-1,3,4-thiadiazole-2-thiol

Catalog No. :
ACRWUI910
CAS No. :
66437-18-1
Molecular Formula :
C4H6N2OS2
Molecular Weight :
162.24

IUPAC Name:5-(methoxymethyl)-1,3,4-thiadiazole-2-thiol

5-(Methoxymethyl)-1,3,4-thiadiazole-2-thiol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$75.00Login to see priceInquiryInquiry
250mg97%$98.00Login to see priceInquiryInquiry
1g97%$181.00Login to see priceInquiryInquiry
5g97%$696.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(Methoxymethyl)-1,3,4-thiadiazole-2-thiol
IUPAC Name5-(methoxymethyl)-1,3,4-thiadiazole-2-thiol
MDL No.MFCD03789155
Molecular FormulaC4H6N2OS2
Molecular Weight162.24
SMILESSC1=NN=C(COC)S1
InChI KeySKGOKGMZDMGZAM-UHFFFAOYSA-N
Synonym5-METHOXYMETHYL-1,3,4-THIADIAZOLE-2-THIOL;3-methoxy-5-(5-methyl-1-tetrazolyl)aniline;1,3,4-Thiadiazole-2(3H)-thione, 5-(methoxymethyl)-;5-(methoxymethyl)-3H-1,3,4-thiadiazole-2-thione;5-(Methoxymethyl)-1,3,4-thiadiazole-2(3H)-thione
CAS No.66437-18-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H315-H319-H332-H335
Precautionary Statement(s)
P233-P260-P261-P264-P270-P271-P280-P301+P312-P302+P352-P304-P304+P340-P305+P351+P338-P312-P321-P330-P332+P313-P337+P313-P340-P362-P403-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACRWUI910 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRWUI910 route product structure diagram
    ACRWUI91066437-18-1
Inquiry

2. ACRWUI910 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRWUI910 route product structure diagram
    ACRWUI91066437-18-1
Inquiry

Comments (0)